Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
82.43
-5.64 (-6.41%)
Jun 1, 2026, 2:57 PM EDT - Market open
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $878.77 million as of June 1, 2026. Its market cap has increased by 228.18% in one year.
Market Cap
878.77M
Enterprise Value
654.17M
1-Year Change
228.18%
Ranking
Category
Stock Price
$82.43
Market Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $878.77M, an increase of 2,003.16%. That is a compound annual growth rate of 77.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 878.77M | 40.11% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexon | 924.07M |
| Pharming Group | 921.89M |
| MeiraGTx Holdings | 914.06M |
| ORIC Pharmaceuticals | 908.88M |
| Sana Biotechnology | 908.62M |
| Xencor | 887.47M |
| Arbutus Biopharma | 886.94M |
| Janux Therapeutics | 876.65M |